LOGAN BELNAP: Open Payments
NPI 1942715636 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,206 in 55 payments from 21 companies in 2025. Trend: 2023 $638 · 2024 $1,014 · 2025 $1,206
Food & beverage: $1,206
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $233 |
| Amgen Inc. | 7 | $226 |
| Novo Nordisk Inc | 6 | $104 |
| Insulet Corporation | 2 | $82 |
| GlaxoSmithKline, LLC. | 4 | $76 |
| Vanda Pharmaceuticals Inc. | 3 | $71 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $60 |
| Viatris Specialty LLC | 3 | $58 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $38 |
| PFIZER INC. | 2 | $32 |
Products named: QULIPTA, REPATHA, EVENITY, Omnipod, TRELEGY ELLIPTA, FANAPT, CAPLYTA, Ozempic.
Industry payments across NV — which companies pay providers there.
